English
Home > Products > cis-2-(Bromomethyl)-2-(2,4-dichlorophenyl)

China cis-2-(Bromomethyl)-2-(2,4-dichlorophenyl) Factory

Every single member from our large efficiency profits team values customers' requirements and organization communication for cis-2-(Bromomethyl)-2-(2,4-dichlorophenyl),CAS NO 61397-56-6,61397-56-6,Ketoconazole intermediate,Ketoconazole advance intermediate, In addition, we would properly guideline the shoppers about the application techniques to adopt our products and solutions as well as the way to select appropriate materials.
cis-2-(Bromomethyl)-2-(2,4-dichlorophenyl), We are going to supply much better items with diversified designs and professional services. We sincerely welcome friends from over the world to visit our company and cooperate with us on the basis of long-term and mutual benefits.

Related Products

Hot Products

  • Pixantrone

    Pixantrone

    Product Name:Pixantrone
    Molecular Formula:C17H19N5O2
    Molecular Weight;325.37
    CAS Registry Number;144510-96-3
  • (S)-(+)-4-Phenyl-2-oxazolidinone

    (S)-(+)-4-Phenyl-2-oxazolidinone

    Product Name:(S)-(+)-4-Phenyl-2-oxazolidinone
    Molecular Formula:C9H9NO2
    Molecular Weight:163.17
    CAS Registry Number:99395-88-7
  • Dapagliflozin propanediol monohydrate

    Dapagliflozin propanediol monohydrate

    Product Name:Dapagliflozin propanediol monohydrate
    Molecular Formula:C24H33ClO8
    Molecular Weight:484.97
    CAS Registry Number:960404-48-2
  • Carbazochrome sodium sulfonate

    Carbazochrome sodium sulfonate

    Product Name:Carbazochrome sodium sulfonate
    Molecular Formula:C10H17N4NaO8S
    Molecular Weight;376.32
    CAS Registry Number;51460-26-5
  • Eptifibatide

    Eptifibatide

    Product Name:Eptifibatide
    Molecular Formula:C35H49N11O9S2
    Molecular Weight;831.96
    CAS Registry Number;188627-80-7
  • 2-(2-aminoethoxy)-1,1-dimethoxyethane

    2-(2-aminoethoxy)-1,1-dimethoxyethane

    Product Name:2-(2-aminoethoxy)-1,1-dimethoxyethane
    Molecular Formula:C6H15NO3
    Molecular Weight:149.19
    CAS Registry Number:1228258-40-9
  • Related Blog
  • Reviews

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept